Intuitive Surgical, Inc. $ISRG Stock Position Increased by Summit Investment Advisors Inc.

Summit Investment Advisors Inc. raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.7% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 23,166 shares of the medical equipment provider’s stock after purchasing an additional 166 shares during the period. Summit Investment Advisors Inc.’s holdings in Intuitive Surgical were worth $11,473,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the company. Nuveen LLC bought a new position in Intuitive Surgical in the 1st quarter worth approximately $1,715,899,000. Goldman Sachs Group Inc. raised its stake in Intuitive Surgical by 26.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider’s stock valued at $1,396,496,000 after acquiring an additional 584,375 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in Intuitive Surgical by 20.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock worth $1,680,922,000 after acquiring an additional 566,979 shares during the period. Jennison Associates LLC grew its stake in shares of Intuitive Surgical by 20.4% in the second quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock worth $1,696,738,000 after purchasing an additional 528,359 shares in the last quarter. Finally, Wellington Management Group LLP increased its holdings in shares of Intuitive Surgical by 15.0% during the first quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock valued at $1,732,975,000 after purchasing an additional 457,080 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In related news, Director Craig H. Barratt sold 2,193 shares of the stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $548.01, for a total value of $1,201,785.93. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the sale, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 98,078 shares of company stock valued at $51,445,892 in the last ninety days. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $560.00 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The firm’s 50 day simple moving average is $471.89 and its 200-day simple moving average is $500.87. The company has a market cap of $200.75 billion, a P/E ratio of 74.07, a price-to-earnings-growth ratio of 4.94 and a beta of 1.62.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same quarter last year, the business posted $1.84 EPS. The company’s revenue was up 22.9% on a year-over-year basis. On average, analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on ISRG shares. Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday. Evercore ISI upped their price target on shares of Intuitive Surgical from $450.00 to $540.00 in a research note on Wednesday, October 22nd. HSBC increased their price objective on shares of Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a report on Thursday, October 23rd. Truist Financial set a $620.00 target price on Intuitive Surgical and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. Finally, UBS Group set a $600.00 price target on Intuitive Surgical and gave the company a “neutral” rating in a research report on Thursday, October 23rd. Two research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $608.92.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.